Page last updated: 2024-10-22

am 251 and Chronic Hepatitis C

am 251 has been researched along with Chronic Hepatitis C in 1 studies

AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.

Research Excerpts

ExcerptRelevanceReference
"CB1R antagonist improved glucose metabolism disorders by an increase in glucose uptake and a decrease in glucose production, and inhibited HCV replication."1.40Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication. ( Chen, MY; Shi, YG; Sun, LJ; Wan, L; Yu, JW; Zhang, XY, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sun, LJ1
Yu, JW1
Wan, L1
Zhang, XY1
Shi, YG1
Chen, MY1

Other Studies

1 other study available for am 251 and Chronic Hepatitis C

ArticleYear
Endocannabinoid system activation contributes to glucose metabolism disorders of hepatocytes and promotes hepatitis C virus replication.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 23

    Topics: AMP-Activated Protein Kinases; Arachidonic Acids; Cell Line; Cell Survival; Coculture Techniques; Cy

2014